ID: ALA2393332

Max Phase: Preclinical

Molecular Formula: C11H11N3O

Molecular Weight: 201.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CNc1ccnc2cc(C(N)=O)ccc12

Standard InChI:  InChI=1S/C11H11N3O/c1-13-9-4-5-14-10-6-7(11(12)15)2-3-8(9)10/h2-6H,1H3,(H2,12,15)(H,13,14)

Standard InChI Key:  CUTSUWHHMDLRRW-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 201.23Molecular Weight (Monoisotopic): 201.0902AlogP: 1.38#Rotatable Bonds: 2
Polar Surface Area: 68.01Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 6.66CX LogP: 0.45CX LogD: 0.39
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.77Np Likeness Score: -1.05

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source